We next analyzed TP53 mutation-associated DEGs in GBM patients from the TCGA database; in U251(KO) and U251(Ctrl) cell lines; in U251(Ctrl) and U251(siTP53) derived from the GEO database. This evidence concerns the gene TP53 and glioblastoma.